Amylyx Pharmaceuticals (AMLX) Change in Receivables (2022 - 2025)
Historic Change in Receivables for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Q3 2025 value amounting to $30000.0.
- Amylyx Pharmaceuticals' Change in Receivables rose 10127.06% to $30000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year increase of 9421.48%. This contributed to the annual value of -$39.6 million for FY2024, which is 26004.69% down from last year.
- According to the latest figures from Q3 2025, Amylyx Pharmaceuticals' Change in Receivables is $30000.0, which was up 10127.06% from -$198000.0 recorded in Q2 2025.
- In the past 5 years, Amylyx Pharmaceuticals' Change in Receivables ranged from a high of $15.9 million in Q2 2023 and a low of -$19.7 million during Q1 2024
- In the last 4 years, Amylyx Pharmaceuticals' Change in Receivables had a median value of -$172500.0 in 2025 and averaged -$333.33.
- As far as peak fluctuations go, Amylyx Pharmaceuticals' Change in Receivables crashed by 97585.59% in 2024, and later soared by 10127.06% in 2025.
- Quarter analysis of 4 years shows Amylyx Pharmaceuticals' Change in Receivables stood at $15.2 million in 2022, then dropped by 29.48% to $10.7 million in 2023, then plummeted by 111.99% to -$1.3 million in 2024, then skyrocketed by 102.34% to $30000.0 in 2025.
- Its Change in Receivables stands at $30000.0 for Q3 2025, versus -$198000.0 for Q2 2025 and -$147000.0 for Q1 2025.